1. Home
  2. ALMS vs TCBX Comparison

ALMS vs TCBX Comparison

Compare ALMS & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • TCBX
  • Stock Information
  • Founded
  • ALMS 2021
  • TCBX 2008
  • Country
  • ALMS United States
  • TCBX United States
  • Employees
  • ALMS N/A
  • TCBX N/A
  • Industry
  • ALMS
  • TCBX Banks
  • Sector
  • ALMS
  • TCBX Finance
  • Exchange
  • ALMS NYSE
  • TCBX Nasdaq
  • Market Cap
  • ALMS 402.6M
  • TCBX 454.9M
  • IPO Year
  • ALMS 2024
  • TCBX 2021
  • Fundamental
  • Price
  • ALMS $3.52
  • TCBX $35.42
  • Analyst Decision
  • ALMS Strong Buy
  • TCBX Hold
  • Analyst Count
  • ALMS 7
  • TCBX 4
  • Target Price
  • ALMS $24.50
  • TCBX $33.67
  • AVG Volume (30 Days)
  • ALMS 841.5K
  • TCBX 66.5K
  • Earning Date
  • ALMS 08-12-2025
  • TCBX 07-23-2025
  • Dividend Yield
  • ALMS N/A
  • TCBX N/A
  • EPS Growth
  • ALMS N/A
  • TCBX 44.43
  • EPS
  • ALMS N/A
  • TCBX 2.95
  • Revenue
  • ALMS $17,389,000.00
  • TCBX $172,270,000.00
  • Revenue This Year
  • ALMS N/A
  • TCBX $17.44
  • Revenue Next Year
  • ALMS N/A
  • TCBX $6.46
  • P/E Ratio
  • ALMS N/A
  • TCBX $12.01
  • Revenue Growth
  • ALMS N/A
  • TCBX 17.40
  • 52 Week Low
  • ALMS $2.76
  • TCBX $20.15
  • 52 Week High
  • ALMS $13.50
  • TCBX $39.45
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • TCBX 69.59
  • Support Level
  • ALMS N/A
  • TCBX $34.36
  • Resistance Level
  • ALMS N/A
  • TCBX $35.66
  • Average True Range (ATR)
  • ALMS 0.00
  • TCBX 1.07
  • MACD
  • ALMS 0.00
  • TCBX 0.27
  • Stochastic Oscillator
  • ALMS 0.00
  • TCBX 95.54

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

Share on Social Networks: